FinCEN Exposes $17.5B in Health Care Fraud in All 50 States including U.S. Virgin Islands and Puerto Rico
St. Croix Times Staff
Washington, D.C. - FinCEN's federal anti-money laundering agency has put a hard number on a problem that patients, providers, insurers, and investigators have seen for years: health care fraud is not a fringe crime. It is a nationwide financial threat.
The U.S. Department of the Treasury’s Financial Crimes Enforcement Network, better known as FinCEN, identified $17.5 billion in suspicious financial activity tied to possible health care fraud. The activity appeared across all 50 states, as well as Puerto Rico and the U.S. Virgin Islands.
That figure does not mean prosecutors have proven every dollar was stolen. It means financial institutions reported transactions that showed signs of fraud, waste, abuse, or laundering connected to the health care system. Still, the scale matters. Banks, credit unions, payment processors, insurers, clinics, and patients all sit somewhere in the path of these schemes.
FinCEN’s findings also come with a practical message: financial institutions are being asked to spot the warning signs sooner.
FinCEN’s findings show how health care fraud moves through the financial system
FinCEN does not deliver medical care, regulate hospitals, or pay insurance claims. Its role is different. It watches how money moves.
Through Bank Secrecy Act reporting, financial institutions file suspicious activity reports when transactions appear to involve fraud, money laundering, terrorist financing, or other financial crimes. In health care fraud cases, that could mean a clinic receiving large payments inconsistent with its size, a shell company moving insurance proceeds, or an account holder withdrawing public program funds in cash soon after deposit.
FinCEN identified $17.5 billion in suspicious financial activity related to potential health care fraud across every state, Puerto Rico, and the U.S. Virgin Islands.
The nationwide reach is a key part of the story. Health care fraud is often discussed as if it happens in isolated hot spots. FinCEN’s findings suggest a broader pattern. Fraud schemes can appear in major cities, rural areas, telehealth networks, home health businesses, pharmacies, laboratories, and billing companies.
The dollar amount also reflects how fraud rarely stops at the fake claim. Once money lands in an account, it often moves again. It may pass through payroll, vendor payments, real estate purchases, luxury goods, cash withdrawals, cryptocurrency platforms, or accounts controlled by relatives and associates.
That financial trail is why banks matter. A suspicious claim may begin inside a health care entity, but the proceeds often surface in ordinary financial behavior that looks wrong when viewed in context.
This is where the term FinCEN health care fraud red flags becomes more than compliance language. It describes a practical set of clues that can help institutions separate normal health care cash flow from activity that deserves closer review.
The schemes behind the suspicious activity are varied and often layered
Health care fraud is not one scheme. It is a family of schemes, and many involve several actors. Some exploit government programs. Others target private insurers or patients directly. Many combine false billing with identity theft, kickbacks, and money laundering.
False billing and phantom services
One of the most common patterns is billing for services that were never provided. A provider or billing entity may submit claims for appointments, tests, supplies, therapy sessions, or procedures that did not happen.
In some cases, the patient exists but never received the service. In others, the patient’s identity was stolen or misused. Fraudsters may collect insurance information through deceptive marketing, fake intake forms, call centers, or data obtained from prior breaches.
False billing can be hard to spot from a bank’s perspective because payments may come from legitimate insurers or government programs. The problem is not always the source of funds. It is whether the account activity matches the business behind it.
Medically unnecessary services
Another major scheme involves services that happened but had little or no medical need. Examples may include excessive lab testing, unnecessary genetic tests, unneeded durable medical equipment, or repeated procedures ordered for financial gain.
These schemes can be profitable because health care billing is complex. A patient may trust that a recommended test is necessary. An insurer may process the claim unless it triggers review. The bank may only see a steady flow of payments into a medical business account.
When the services involve high reimbursement rates, even a small patient group can generate large deposits.
Kickbacks and patient brokering
Kickbacks distort medical judgment. In these arrangements, someone receives payment for steering patients, prescriptions, referrals, medical equipment orders, or lab work to a specific provider or company.
The payment may be disguised as:
Consulting fees
Marketing expenses
Management fees
Rental payments
Sham employment
Referral bonuses hidden in vendor invoices
Patient brokering can be especially harmful in behavioral health, addiction treatment, laboratory testing, and telemedicine-linked schemes. It turns patients into revenue sources rather than people seeking care.
From a financial institution’s view, the challenge is that kickbacks may look like ordinary business expenses. The red flag appears when the payments do not fit the stated business purpose or when money flows repeatedly between related parties with unclear roles.
Telemedicine and durable medical equipment fraud
Telemedicine has expanded access to care, especially for people who face travel, mobility, or scheduling barriers. Fraudsters have also used telemedicine models to create distance between the patient, the ordering provider, and the company billing for goods or services.
A common pattern involves marketers collecting patient information, a remote consultation of limited value, and orders for braces, testing kits, medications, or other reimbursable items. The patient may receive products they did not request, do not need, or barely understand.
Durable medical equipment schemes can include braces, wheelchairs, diabetic supplies, catheters, and other medical products. The fraud often depends on volume. A company may submit claims at scale, then move funds quickly through layered accounts.
Pharmacy, prescription, and lab schemes
Pharmacy fraud can involve billing for prescriptions never filled, dispensing expensive drugs instead of cheaper suitable alternatives, or charging for compounded medications with inflated prices. Some schemes involve recurring refills that patients did not ask for.
Laboratory schemes may involve panels of tests ordered broadly instead of based on medical need. Genetic testing fraud has drawn attention in recent years because one test can carry a high reimbursement value, and patients may be recruited through events, calls, or online forms.
Financial clues can include sudden large deposits, payments to marketers, high refund rates, or transfers to entities outside the normal health care supply chain.
Money laundering after the fraud
The second half of the crime is moving the money.
Once fraudulent proceeds enter an account, bad actors may try to hide ownership, source, or purpose. They may use shell companies, nominee owners, layered transfers, cash withdrawals, cashier’s checks, wires, or purchases of property and vehicles.
This stage is where banks and other financial institutions have the clearest view. They may not know whether a medical claim was false, but they can see whether account behavior fits the customer profile.
For example, a new medical supply company with little history may receive large health care payments, immediately transfer funds to unrelated companies, send wires abroad, and make cash withdrawals inconsistent with its stated operations. Each action may have an explanation. Together, they raise concern.
The damage reaches far beyond stolen money
Health care fraud is often described in dollars, but the harm is broader than financial loss.
When fraud drains public programs, fewer resources remain for legitimate care. Medicare, Medicaid, and private insurance plans absorb losses through higher costs, tighter controls, delayed payments, or reduced coverage options. Honest providers may face more audits and paperwork because bad actors have abused the system.
Patients can suffer direct harm as well. A person whose identity is used in false billing may later face confusion in medical records or insurance files. If fraudulent claims exhaust a benefit, the patient may have trouble getting needed care approved. If unnecessary testing or equipment is pushed on a patient, the harm can be physical, emotional, and financial.
Fraud can also damage trust.
Health care depends on trust among patients, clinicians, insurers, pharmacies, laboratories, and public agencies. When criminal networks enter the system, they make every part of that chain more suspicious. Legitimate providers may find themselves competing against actors who use illegal referral payments or aggressive billing tactics.
The result is a heavier burden on everyone trying to do things correctly.
There is another concern: fraud proceeds can fund other crimes. Money from health care schemes may support tax evasion, identity theft rings, drug trafficking, corruption, or further financial fraud. That is why FinCEN treats these cases as both health care problems and financial crime problems.
FinCEN’s red flags give banks a sharper checklist
FinCEN’s advisory is aimed at financial institutions, but the warning signs are useful for anyone who wants to understand how health care fraud appears in the real economy.
A red flag does not prove crime. Banks are expected to look at the full picture, including the customer’s business model, account history, geography, transaction size, and expected activity. Still, FinCEN’s guidance points to several patterns that deserve attention.
Unusual payments for the type of business
A clinic, laboratory, pharmacy, or medical supply company may receive deposits that do not match its size, staffing, location, or known services.
Examples include:
A recently formed health care company receives very large payments soon after opening.
A small provider receives deposits from many insurers across several states.
A business with no clear medical presence receives health care-related payments.
Account volume rises sharply without a clear business reason.
Banks often build customer profiles when accounts open. When the activity sharply differs from that profile, the mismatch can be meaningful.
Rapid movement of funds after health care deposits
Fraud proceeds often move quickly. FinCEN’s red flags include patterns where health care payments are followed by immediate transfers, cash withdrawals, or payments to unrelated entities.
Concerning behavior may include:
Large deposits followed by same-day withdrawals
Transfers to shell companies or newly formed entities
Wires to high-risk jurisdictions without a clear business purpose
Payments to people or businesses with no apparent link to health care
Repeated cashier’s check purchases after insurance or program deposits
Fast movement can suggest that the account is being used as a pass-through rather than for normal operations.
Payments that suggest kickbacks or referral schemes
Health care businesses have legitimate marketing, staffing, and vendor costs. The concern arises when payments appear tied to patient referrals or claim generation rather than real services.
Red flags may include recurring payments to marketers, recruiters, consultants, or call centers that are unusually high or poorly documented. Payments to providers or entities that appear to correspond with patient volume may also deserve review.
Financial institutions are not expected to diagnose a medical relationship. They are expected to ask whether the money flow makes sense.
Shell companies and hidden ownership
Fraud networks often use entities that obscure who controls the money. A bank may see companies with vague names, shared addresses, nominee owners, or overlapping signers.
A health care fraud structure may include:
A billing company that receives funds for several clinics
A management company that drains revenue through fees
A marketing company that pays patient recruiters
An equipment company linked to the same people behind ordering providers
Beneficial ownership information, account opening data, public records, and transaction patterns can help institutions identify hidden links.
Patient identity theft and account misuse
Some red flags involve patient information. For example, a financial institution may notice consumer complaints, unusual refund activity, disputed payments, or law enforcement inquiries tied to improper billing.
A bank may also identify customers who collect personal or insurance information but do not appear to provide real medical services. This can show up through merchant activity, payment processor records, or repeated chargebacks.
Geographic and network inconsistencies
Health care does cross state lines, especially with telemedicine, specialty labs, national pharmacies, and equipment suppliers. Still, geography can be revealing.
A small local provider receiving payments tied to patients nationwide may be legitimate, but it requires context. A rural clinic with large deposits from distant regions, payments to out-of-state marketers, and no clear telehealth model may present higher risk.
FinCEN’s nationwide findings make this point clear. Fraud networks do not respect state borders, and suspicious activity can connect accounts across many regions.
Why financial institutions are central to the response
Banks are not doctors, auditors, or prosecutors. They do not decide whether a treatment was necessary or whether a claim should have been paid. Their role is to identify suspicious financial patterns and report them when required.
That role matters because financial institutions may see connections that a single insurer or clinic cannot. One bank may spot related companies moving money between accounts. A payment processor may detect abnormal chargeback patterns. A credit union may notice an account holder receiving medical funds and immediately sending wires to unrelated parties.
Strong monitoring can also protect financial institutions from being used as conduits for stolen public funds. In health care fraud cases, the cost of weak controls can include regulatory scrutiny, reputational damage, subpoenas, account closures, and exposure to criminal networks.
FinCEN’s advisory does not call for banks to treat every health care customer as suspicious. The health care sector has many legitimate business models with complex flows of money. The point is to improve review where the facts do not add up.
Practical steps include:
Updating monitoring rules for health care-related businesses
Training staff on medical billing and fraud typologies
Reviewing beneficial ownership and control information
Watching for rapid movement after insurer or government deposits
Comparing account activity with the customer’s stated business
Escalating patterns that involve shell entities, kickbacks, or identity theft indicators
The best results come from context. A single large deposit may be normal for a specialty provider. A single wire may have a valid explanation. But a new entity with unclear ownership, large health care deposits, rapid transfers, and payments to marketers deserves closer scrutiny.
The takeaway for the health care system
FinCEN’s findings are a warning that health care fraud is not only a billing issue. It is a financial crime issue, a patient protection issue, and a public trust issue.
The $17.5 billion in suspicious activity shows how much money can move through the system before fraud is proven or stopped. It also shows why banks and financial institutions have become essential partners in detection.
For patients, the lesson is to review insurance statements, question unfamiliar claims, and protect personal medical information. For providers, it is to maintain clean billing practices and avoid referral arrangements that create legal risk. For financial institutions, it is to treat FinCEN’s red flags as a call to sharpen monitoring, not as a substitute for careful judgment.
Health care fraud thrives when complexity hides misconduct. Better financial reporting, stronger account review, and faster recognition of suspicious patterns can make that hiding place smaller.
This post is for informational purposes only and does not provide legal, medical, or financial advice.
